A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation

We created a model to predict the development of liver carcinogenesis in patients with chronic hepatitis B (CHB) undergoing entecavir (ETV) therapy and to validate the accuracy using an independent dataset. A total of 328 CHB subjects were analyzed. Subjects were randomly assigned into 2 groups: the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikawa, Hiroki, Nishijima, Norihiro, Enomoto, Hirayuki, Sakamoto, Azusa, Nasu, Akihiro, Komekado, Hideyuki, Nishimura, Takashi, Kita, Ryuichi, Kimura, Toru, Iijima, Hiroko, Nishiguchi, Shuhei, Osaki, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023923/
https://www.ncbi.nlm.nih.gov/pubmed/27603400
http://dx.doi.org/10.1097/MD.0000000000004832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023923/
https://www.ncbi.nlm.nih.gov/pubmed/27603400
http://dx.doi.org/10.1097/MD.0000000000004832

Ejemplares similares